Grey Wolf Therapeutics
Grey Wolf Therapeutics is developing next generation immunotherapies that illuminate non-responsive tumours for destruction by the immune system.
- What
- Life Sciences
- When
- Sept 2017
- CEO
- Peter Joyce
- Status
- Private
- Investment
- Active
- OSE Board Director
- Sally Dewhurst